Mumbai, Jan. 31 -- The acquisition will be executed through MPS North America LLC, a wholly owned subsidiary of MPS. The transaction is expected to be completed on or before 10 February 2026, subject to the fulfilment of customary closing conditions, the company said in a regulatory filing.

The acquisition will be carried out for a cash consideration of $16.50 million, subject to customary adjustments.

Founded in 1999, Unbound Medicine provides digital medical reference tools, clinical decision-support solutions and healthcare learning platforms. Its services are delivered through proprietary mobile and web-based platforms and follow a subscription-led institutional business model. The company serves medical schools, hospital systems an...